About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 197 record(s)
Req # A-2019-001508
Adverse Drug Reactions (ADRs). Report numbers: 000722619, E2B_02581711, E2B_02578676, 000724834, E2B_02490456, E2B_02702480, E2B_02543606, E2B_02595468, E2B_02439146, E2B_01971223, E2B_01955026, E2B_01971468, E2B_01975127 E2B_01975402, E2B_01986048, E2B_02013766, E2B_02038042, E2B_02045530, E2B_02056112, E2B_02064312.Organization: Health Canada
February 2022
Req # A-2019-002054
Adverse Drug Reaction (ADR). Report number: E2B_02803860.Organization: Health Canada
February 2022
Req # A-2019-002063
Adverse Drug Reaction (ADR) for IXAZOMIB. Report number: E2B_02897412.Organization: Health Canada
February 2022
Req # A-2020-000009
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_02579328, E2B_02582914, E2B_02585300, E2B_02525751, E2B_00749104, E2B_02526229, E2B_02511290, E2B_01777639, E2B_02589763, E2B_02515457, E2B_02535912, E2B_02515576, E2B_02516803, E2B_02531115, E2B_02621109.Organization: Health Canada
February 2022
Req # A-2020-000057
Adverse Drug Reaction (ADR). Report number: 02517334.Organization: Health Canada
February 2022
Req # A-2020-000078
Adverse Drug Reaction (ADR) for VANDETANIB. Report number: E2B_02536410.Organization: Health Canada
February 2022
Req # A-2020-000716
Adverse Drug Reactions (ADRs) for RIFAMPICIN. Report numbers: 909979, 910324, 912229.Organization: Health Canada
February 2022
Req # A-2020-000874
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108442-356.Organization: Health Canada
February 2022
Req # A-2020-001057
Adverse Drug Reactions (ADRs). Report numbers: Adverse Drug Reactions (ADRs): 000726262, 000726264, 000726269, 000726309, 000726316, 000726332, 000726337, 000726340, 000726371, 000726397, 000726399, 000726400, 000726403, 000726404, 000726405, 000726406, 000726432, 000726441, 000726442, 000726443.Organization: Health Canada
February 2022
Req # A-2020-001511
Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: 000913774, E2B_03276869.Organization: Health Canada
February 2022